SC Filed 2020-03-31 Event — SEC 0001185185-20-000400 →

Dangdai International Group Co. Ltd → Cellular Biomedicine Group, Inc.

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 6/100

Passive Schedule 13G filer baseline

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

18 13D/G filings on this issuer

17 other filings besides this one

Filer Track Record

5 filings by this filer

4 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other 13D/G Filings on Cellular Biomedicine Group, Inc.

Filed	Form	Filer	Stake	Shares
2020-08-12	SC	Dangdai International Group Co. Ltd	—	—	view →
2020-08-12	SC	Liu Tony	—	—	view →
2020-06-25	SC	Dangdai International Group Co. Ltd	—	—	view →
2020-06-24	SC	HILLHOUSE CAPITAL ADVISORS, LTD.	—	—	view →
2020-06-24	SC	Liu Tony	—	—	view →
2020-04-01	SC	Liu Tony	—	—	view →
2020-04-01	SC	Sailing Capital Overseas Investments Fund, LP	—	—	view →
2020-04-01	SC	TF Venture Capital Management Co., Ltd.	—	—	view →
2020-03-30	SC	HILLHOUSE CAPITAL ADVISORS, LTD.	—	—	view →
2020-02-24	SC	Dangdai International Group Co. Ltd	—	—	view →
2020-02-21	SC	Sailing Capital Overseas Investments Fund, LP	—	—	view →
2020-02-21	SC	Liu Tony	—	—	view →
2020-02-21	SC	HILLHOUSE CAPITAL ADVISORS, LTD.	—	—	view →
2020-02-21	SC	TF Venture Capital Management Co., Ltd.	—	—	view →
2020-02-03	SC	Dangdai International Group Co. Ltd	—	—	view →
2020-01-30	SC	HILLHOUSE CAPITAL ADVISORS, LTD.	—	—	view →
2020-01-30	SC	Liu Tony	—	—	view →

Other Filings by Dangdai International Group Co. Ltd

Filed	Form	Issuer	Stake	Shares
2020-08-12	SC	Cellular Biomedicine Group, Inc.	—	—	view →
2020-06-25	SC	Cellular Biomedicine Group, Inc.	—	—	view →
2020-02-24	SC	Cellular Biomedicine Group, Inc.	—	—	view →
2020-02-03	SC	Cellular Biomedicine Group, Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →